Switch from dabrafenib/trametinib combination therapy to encorafenib/binimetinib combination therapy with transition of serum lactate dehydrogenase level in melanoma: A case report

Dermatologic Therapy(2022)

引用 0|浏览0
暂无评分
摘要
Dermatologic TherapyEarly View e15301 LETTER Switch from dabrafenib/trametinib combination therapy to encorafenib/binimetinib combination therapy with transition of serum lactate dehydrogenase level in melanoma: A case report Takahiko Sato, Takahiko Sato Department of Dermatology and Plastic Surgery, Akita University Graduate School of Medicine, Akita, JapanSearch for more papers by this authorMai Noto, Mai Noto Department of Dermatology and Plastic Surgery, Akita University Graduate School of Medicine, Akita, JapanSearch for more papers by this authorMasayuki Yamada, Masayuki Yamada Department of Dermatology and Plastic Surgery, Akita University Graduate School of Medicine, Akita, JapanSearch for more papers by this authorMichihiro Kono, Corresponding Author Michihiro Kono miro@med.akita-u.ac.jp orcid.org/0000-0003-2639-1583 Department of Dermatology and Plastic Surgery, Akita University Graduate School of Medicine, Akita, Japan Correspondence Michihiro Kono, Department of Dermatology and Plastic Surgery, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita 010-8543, Japan. Email: miro@med.akita-u.ac.jpSearch for more papers by this author Takahiko Sato, Takahiko Sato Department of Dermatology and Plastic Surgery, Akita University Graduate School of Medicine, Akita, JapanSearch for more papers by this authorMai Noto, Mai Noto Department of Dermatology and Plastic Surgery, Akita University Graduate School of Medicine, Akita, JapanSearch for more papers by this authorMasayuki Yamada, Masayuki Yamada Department of Dermatology and Plastic Surgery, Akita University Graduate School of Medicine, Akita, JapanSearch for more papers by this authorMichihiro Kono, Corresponding Author Michihiro Kono miro@med.akita-u.ac.jp orcid.org/0000-0003-2639-1583 Department of Dermatology and Plastic Surgery, Akita University Graduate School of Medicine, Akita, Japan Correspondence Michihiro Kono, Department of Dermatology and Plastic Surgery, Akita University Graduate School of Medicine, 1-1-1 Hondo, Akita 010-8543, Japan. Email: miro@med.akita-u.ac.jpSearch for more papers by this author First published: 04 January 2022 https://doi.org/10.1111/dth.15301Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article. Early ViewOnline Version of Record before inclusion in an issuee15301 RelatedInformation
更多
查看译文
关键词
encorafenib/binimetinib combination therapy,melanoma,serum lactate dehydrogenase level,dabrafenib/trametinib
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要